Home Infusion Smart Pump Accessories Market : Global Industry Analysis and Opportunity Assessment, 2036

How big is home infusion smart pump accessories market size?

USD 343.7 million in 2026 and USD 875.4 million by 2036 at a 9.8% CAGR.

Demand for Home Infusion Smart Pump Accessories is projected to expand at 9.8% CAGR between 2026 and 2036, increasing valuation from USD 343.7 million in 2026 to USD 875.4 million by 2036. In its February 2026 report, the Centers for Medicare & Medicaid Services recorded 27,834 home infusion therapy service visits during 2024. This high patient volume drives a steady demand for fresh accessories throughout ongoing treatment cycles. Medical teams care for patients outside of hospitals relying significantly on smart connected pumps and disposable tubing sets. Security locks and backup batteries keep such devices running safely between nurse check-ups. Specialized carrying pouches and smart software allow patients to move around freely with their doctors monitoring them from afar. They need a continuous supply of replacement parts for their long-term medical care as more people adopt home infusion devices.

Healthcare organizations focus on distinct priorities on purchasing pump accessories across different regions. Procurement managers in the United States and Germany strictly demand proven device reliability and prompt local technical support. Medical providers in China and India prioritize affordable disposable supplies integrating seamlessly into their home-nursing workflows. Regulatory compliance also plays a major role in shaping purchasing decisions. In June 2026, the Centers for Medicare & Medicaid Services listed 6 approved home infusion therapy accrediting organizations. This strict regulatory oversight motivates American health programs to evaluate their suppliers through detailed documentation and quality audits.

Key Takeaways for the Home Infusion Smart Pump Accessories Market

• Demand for home infusion smart pump accessories is driven by recurring therapy outside acute facilities. Buyers favor pump-compatible sets and service support preserving treatment continuity.
• Consumable is forecast to garner 42.0% share of product type in 2026, influenced by repeated set replacement across supervised infusion programs.
• Monitoring is estimated to lead application with 28.0% share in 2026, backed by remote status review helping providers identify interruptions between visits.
• Device-quality events and fragmented payer rules restrict adoption across multi-provider home infusion programs.
• Competition focuses on B. Braun, Baxter, ICU Medical, Fresenius Kabi, Eitan Medical, Moog Medical, Micrel Medical, and BD. Providers differentiate through pump compatibility and service coverage.

Analyst Perspective

“Reliable home infusion delivery requires every pump accessory to support accurate dosing throughout treatment without creating avoidable interruptions for patients or clinical teams. Providers assess administration-set compatibility and alarm response based on documented performance records prior to approving accessories for recurring use across distributed care programs. Supplier confidence strengthens depending on consistent product availability and clear corrective procedures helping nursing teams resolve equipment issues without delaying prescribed therapy. Long-term adoption increases as accessories demonstrate dependable operation across repeated infusion cycles and preserve confidence among patients and payers.”

- Anurag Sharma, Principal Analyst for Healthcare at Future Market Insights

How is home infusion smart pump accessories market segmented?

The home infusion smart pump accessories industry is segmented by product type, care setting, application, end user, and region.

The home infusion smart pump accessories market is segmented by product type, care setting, application, end user, and region. Product type coverage includes software, wearable, diagnostic kit, consumable, and device accessory options serving distinct therapy-support requirements. Care setting coverage addresses hospital and home care together with ambulatory center, retail clinic, and decentralized trial site. Application coverage spans monitoring, diagnosis, workflow automation, therapy support, and infection control. End-user coverage includes hospitals, payers, diagnostic labs, medtech firms, and patients. Regional coverage includes North America and Latin America together with Western Europe. Eastern Europe and East Asia extend analysis across established healthcare systems. South Asia and Pacific with Middle East and Africa complete geographic assessment.

What makes consumable central to product type selection?

Consumable demand reflects repeated use of administration sets and tubing during scheduled therapy. Pump compatibility shapes purchasing since line design affects priming and delivery performance. USA Food and Drug Administration listed 14,280 IVENIX blood-products administration sets in a recall posted during June 2025, placing assembly integrity inside routine replenishment review. Replacement frequency creates recurring orders across IV therapy and vein access devices. Provider review includes packaging integrity and lot traceability during routine replenishment.

• Consumable is predicted to represent 42.0% share of product type in 2026, driven by repeated set use across supervised therapy programs. Recurring replacement connects treatment volume with repeated accessory orders across home infusion providers.
• Software and wearable support connected supervision across mobile therapy programs. Diagnostic kit and device accessory address testing and equipment operation through separate purchasing cycles.

Why does Hospital retain a central Care Setting position?

Hospital use supports therapy initiation and patient training prior to transfer into home care. Clinical teams establish pump settings and line protocols during supervised treatment. Centers for Medicare & Medicaid Services reported 366 participating hospitals in its December 2024 publication, expanding home-based pathways requiring aligned pump settings and accessory support. Discharge planning links hospital records with home providers and hospital-at-home equipment rental services. Supplier performance during hospital deployment influences confidence across later community use.

• By care setting, hospital is anticipated to account for 26.0% share in 2026 owing to supervised therapy initiation and discharge preparation. Initial programming and competency assessment support its central role across complex infusion pathways.
• Home care extends treatment into patient residences through scheduled nursing oversight. Ambulatory center and retail clinic serve shorter episodes as decentralized trial site supports protocol-led administration.

How does monitoring support application demand?

Monitoring supports review of infusion status and alarm events during therapy outside clinical facilities. Connected records help service teams identify interruptions without immediate travel. Baxter reported a 50.3% reduction in hard-limit alerts following smart-pump electronic-record integration in December 2025, supporting monitoring tools focused on actionable clinical exceptions. Provider attention centers on actionable information instead of unrestricted data collection. Similar oversight needs influence patient-controlled analgesia pumps across pain therapy programs.

• In 2026, monitoring is expected to hold 28.0% share as it is influenced by alarm oversight between clinical visits. Status review supports timely intervention across scheduled home infusion sessions.
• Diagnosis and workflow automation support clinical decisions together with care coordination. Therapy support and infection control protect treatment execution across repeated line access.

What buyer need supports Payers across End User demand?

Payers assess whether home infusion accessories support safe therapy at an appropriate site of care. Coverage review considers device suitability and service documentation together with treatment duration. Centers for Medicare & Medicaid Services attributed 72.5% of improper infusion-pump payments during the 2024 reporting period to insufficient documentation in its February 2026 update, increasing payer scrutiny of medical-necessity and delivery records. Claims consistency supports evaluation across repeated therapy episodes. Similar economic review affects pain management devices used outside acute settings.

• By end user, payers are likely to hold 26.0% share in 2026 since payment review governs therapy eligibility and reimbursement. Coverage authority connects clinical evidence with access across eligible home infusion programs.
• Hospitals establish therapy protocols as Diagnostic labs support selected testing requirements. Medtech firms supply compatible systems and patients evaluate usability during daily treatment.

What are drivers, restraints, and opportunities in home infusion smart pump accessories market?

Home-based nursing capacity supports therapy expansion and device quality concerns slow supplier approval. Connected support creates expansion potential across monitored infusion programs.

• Driver: Home nursing services extend supervised infusion pathways beyond acute facilities. Scheduled clinical visits support pump setup and patient education across home-based programs.
• Restraint: Administration-set failures increase clinical review and replacement duties across provider networks. Providers investigate delivery interruptions and replace affected sets prior to resuming therapy.
• Opportunity: Connected pump support improves remote troubleshooting across complex therapy programs. Care teams receive device-status information and resolve selected issues without an unscheduled site visit.

Home nursing services expand the operating base for supervised therapy outside hospitals. National Health Commission reported nearly 6,000 medical institutions providing home-based nursing services in May 2026, increasing access to clinical support during chronic care and rehabilitation. Service availability improves the practical base for pump training and accessory replenishment across home infusion programs.

Administration-set quality directly affects medication delivery and supplier confidence. USA Food and Drug Administration listed 187,464 units in a B. Braun administration-set recall posted during November 2025, citing backflow and priming concerns across pump or gravity use. Quality events increase review of line compatibility and replacement procedures across home providers.

Connected support creates expansion potential across home oncology programs. Eitan Medical reported a 75.0% reduction in troubleshooting calls during an Avoset oncology home infusion program in September 2025, linking remote data access with easier patient support. Service outcomes strengthen purchasing interest in connected accessories and wearable injectors serving mobile therapy.

How are country CAGRs aligned in home infusion smart pump accessories market?

Country	CAGR
China	13.2%
India	12.3%
United States	11.3%
Germany	10.3%
United Kingdom	9.3%
Japan	8.3%

Source: Future Market Insights analysis, 2026.

How do country-level CAGRs compare in home infusion smart pump accessories market?

Country comparison shows a gradual step-down across profiled markets. China occupies the upper forecast position and India follows at a limited distance. United States forms the middle rate band. Germany and United Kingdom follow under documentation-led purchasing systems. Japan completes the disclosed comparison under established home-care practices. A 4.9 percentage-point spread separates China from Japan. Profiled rates reflect different service capacity and coverage conditions.

• China establishes East Asia as the upper development cluster across markets shown.
• India follows China through expanding community-care pathways and home-service reach.
• United States occupies the middle rate position under established home infusion programs.
• Germany and United Kingdom form the next band through structured quality and contracting reviews.
• Japan completes the disclosed range through long-duration care needs and compact device preferences.

Markets carrying similar CAGRs may present different entry conditions through payer rules and nursing capacity. Full report coverage extends across North America and Latin America together with Western Europe. Eastern Europe and East Asia extend geographic assessment. South Asia and Pacific with Middle East and Africa complete full coverage.

Country-wise Analysis

• Home infusion smart pump accessories demand in China is projected to expand at 13.2% CAGR from 2026 to 2036, led by expanding home-nursing coverage. Local service networks increase opportunities for supervised therapy and recurring set replacement. National Health Commission reported over 3,000 medical institutions offering internet-supported nursing during May 2024, extending care access into homes and communities. Pump suppliers may benefit from products suited to nurse-led setup and remote follow-up.
• Press Information Bureau reported 182,944 Ayushman Arogya Mandirs operational across India in February 2026, extending primary-care touchpoints across urban and rural communities. Facility reach supports therapy referral and follow-up for patients receiving repeated infusions. Industry in India is anticipated to rise at 12.3% CAGR by 2036, aided by expanding community-care pathways and local service coordination.
• Established home infusion programs support recurring accessory replacement across United States provider networks. Sales in United States are estimated to advance at 11.3% CAGR between 2026 and 2036, influenced by established payer coverage and specialist service capacity. USA Food and Drug Administration listed 13,613 Plum Solo pumps in a correction posted during June 2026, reinforcing software-alert review and field-support requirements. Supplier selection favors documented update processes and compatible consumables.
• Federal Ministry of Health increased qualifying outpatient care audit intervals from one year to two years in December 2025, rewarding documented quality performance across German care providers. Supplier service records and lot traceability support confidence across home-care channels. Industry in Germany is likely to grow at 10.3% CAGR during the study period, reflecting structured quality assessment and local technical support.
• Homecare medicine contracting supports coordinated supply across United Kingdom health services. Demand in United Kingdom is projected to record 9.3% CAGR during the forecast period, driven by established homecare medicine pathways and centralized supplier review. East of England NHS Collaborative Hub outlined a contract arrangement serving 4 English areas in May 2025, supporting coordinated service access across participating trusts. Contract coverage encourages suppliers to align pump accessories with shared delivery standards.
• Statistics Bureau reported older residents represented 29.3% of Japan’s population in 2024, sustaining demand for long-duration care outside hospitals. Older patient needs favor compact pumps and simple accessory handling. Sales in Japan are predicted to increase at 8.3% CAGR by 2036, guided by extended therapy needs and infusion pumps suited to home use.

Who are notable companies in home infusion smart pump accessories market?

B. Braun, Baxter, ICU Medical, Fresenius Kabi, Eitan Medical, Moog Medical, Micrel Medical, and BD are notable companies shaping home infusion smart pump accessories demand.

Competition centers on pump compatibility and recurring consumable supply across home therapy programs. Integrated suppliers combine pumps with administration sets and service support. Ambulatory specialists focus on compact systems suited to mobile treatment. Buyer review covers alarm handling and replacement availability together with training. Geographic service reach influences renewal confidence across provider networks.

• B. Braun and Baxter compete led by integrated infusion portfolios and recurring administration-set supply. Provider teams assess compatibility records and field support during system review.
• ICU Medical and Fresenius Kabi compete based on connected pump platforms and implementation services. Health systems examine configuration control and training support across multi-site transitions.
• Eitan Medical and Moog Medical focus on ambulatory infusion across homecare programs. Customer teams evaluate portability and remote support together with therapy flexibility.
• Micrel Medical and BD add ambulatory delivery together with vascular-access and line-management capabilities. Purchasing teams compare accessory availability and clinical support across treatment pathways.

Competitive Benchmarking: Home Infusion Smart Pump Accessories Market

Company	Pump and Accessory Breadth	Home Infusion Capability	Software and Monitoring	Service Reach
B. Braun	High	Medium	High	Global
Baxter	High	Medium	High	Global
ICU Medical	High	High	High	Global
Fresenius Kabi	High	Medium	High	Global
Eitan Medical	Medium	High	High	International
Moog Medical	Medium	High	High	North America and Europe
Micrel Medical	Medium	High	High	International
BD	High	Medium	High	Global

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Home Infusion Smart Pump Accessories Market

• In March 2025, Baxter received USA Food and Drug Administration clearance for Solution Administration Sets. Company information connected the cleared sets with intravascular fluid delivery across compatible infusion workflows.
• In July 2025, B. Braun Medical received USA Food and Drug Administration clearance for Infusomat Space Volumetric Infusion Pump Administration Sets. Company information connected the cleared set family with pump-compatible fluid delivery across infusion programs.
• In October 2025, BD received USA Food and Drug Administration clearance for the BD Alaris Pump Infusion Set. Company information connected the cleared set with administration-set compatibility across Alaris pump workflows.

Key Companies in Home Infusion Smart Pump Accessories Market

Integrated Infusion Systems

• B. Braun
• Baxter
• ICU Medical
• Fresenius Kabi
• BD

Connected Home Infusion

• Eitan Medical
• Moog Medical

Ambulatory Pump Specialists

• Micrel Medical

Home Infusion Smart Pump Accessories Market Report Scope

Coverage field	Report scope
Market breakdown	Home infusion smart pump accessories breakdown includes product type, care setting, application, end user, and region.
Quantitative Units	USD million in 2026 to USD million by 2036 at CAGR.
Market Definition	Home infusion smart pump accessories include software and wearables supporting pump use outside acute facilities. Diagnostic kits and consumables cover testing together with repeated fluid delivery. Device accessories include batteries and locks together with carrying systems. Standalone infusion drugs and unrelated homecare equipment are excluded.
Regions Covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa.
Countries Covered	China, India, United States, Germany, United Kingdom, Japan and more than 30 additional countries complete full report coverage.
Key Companies Profiled	B. Braun, Baxter, ICU Medical, Fresenius Kabi, Eitan Medical, Moog Medical, Micrel Medical, and BD.
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down methodology uses segment shares and country CAGRs. Company activity and buyer adoption support final reconciliation.

Source: Future Market Insights analysis, 2026.

Home Infusion Smart Pump Accessories Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing and Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

Source: Future Market Insights analysis, 2026.

Home Infusion Smart Pump Accessories Market by Segments

Home Infusion Smart Pump Accessories Market segmented by Product Type:

• Software
• Wearable
• Diagnostic Kit
• Consumable
• Device Accessory

Home Infusion Smart Pump Accessories Market segmented by Care Setting:

• Hospital
• Home Care
• Ambulatory Center
• Retail Clinic
• Decentralized Trial Site

Home Infusion Smart Pump Accessories Market segmented by Application:

• Monitoring
• Diagnosis
• Workflow Automation
• Therapy Support
• Infection Control

Home Infusion Smart Pump Accessories Market segmented by End User:

• Hospitals
• Payers
• Diagnostic Labs
• Medtech Firms
• Patients

Home Infusion Smart Pump Accessories Market segmented by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
  • East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• Centers for Medicare & Medicaid Services. (2026, February). HIT monitoring report.
• Centers for Medicare & Medicaid Services. (2026, June 29). Accrediting organizations (AOs).
• USA Food and Drug Administration. (2025, June 6). Class 1 device recall IVENIX infusion system LVP blood products administration set.
• Adams, D. N., Wolfe, A. J., Warren, J. M., & Hughes, D. L. (2024, December 17). Lessons from CMS’ Acute Hospital Care at Home initiative. Centers for Medicare & Medicaid Services.
• Baxter International Inc. (2025, December 11). Baxter presents real-world data at American Society of Health-System Pharmacists meeting demonstrating smart infusion pump electronic medical record integration may improve patient safety and nursing bedside productivity.
• Centers for Medicare & Medicaid Services. (2026, February 11). Infusion pumps & related drugs.
• National Health Commission of the People’s Republic of China. (2026, May 12). China builds robust nursing workforce amid healthcare push.
• USA Food and Drug Administration. (2025, November 26). Class 2 device recall IV administration set.
• Eitan Medical. (2025, September 29). Allegheny Health Network enhances the patient experience for oncology home infusion with the Avoset™ infusion system.
• State Council of the People’s Republic of China. (2024, May 12). Internet-powered nursing services available in all Chinese provinces: NHC.
• Press Information Bureau. (2026, February 3). Update on AAMs.
• USA Food and Drug Administration. (2026, June 5). Class 2 device recall Plum Solo Precision IV pump.
• Federal Ministry of Health. (2025, December 19). Changes in the areas of health and long-term care in 2026.
• East of England NHS Collaborative Hub. (2025, May 23). Homecare medicines services.
• Statistics Bureau of Japan. (2025, April 14). Current population estimates as of October 1, 2024.
• USA Food and Drug Administration. (2025, March 14). 510(k) premarket notification: Solution administration sets.
• USA Food and Drug Administration. (2025, July 24). 510(k) premarket notification: Infusomat Space volumetric infusion pump administration sets.
• USA Food and Drug Administration. (2025, October 30). 510(k) premarket notification: BD Alaris pump infusion set.

This bibliography supports disclosed body evidence and is not exhaustive. The full report coverage includes complete source records and detailed citations.

This Report Answers

• How do product type choices influence demand across recurring pump use?
• What criteria guide providers evaluating consumables and device accessories?
• Why do country CAGRs differ across profiled markets?
• What companies compete through pump compatibility and homecare support?
• How are forecasts validated through bottom-up and top-down analysis?
• What evidence supports supplier review prior to multi-site deployment?
• Why do alarm support and lot traceability influence supplier selection?
• How does fragmented coverage restrict adoption across home infusion programs?
• How do service records influence approval across clinical and payer teams?
• What company capabilities improve confidence and recurring accessory purchasing?